Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 6;139(1):73–86. doi: 10.1182/blood.2021012327

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by The American Society of Hematology

This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 1. — IGH-BCL2⁺DLBCLs manifest high levels of endogenous SOX9. (A) immunohistochemical staining of SOX9 protein in tissue samples from a DLBCL cohort (n = 114). Original magnification ×200. Bar represents 100 μm. SOX9 immunostainings are denoted as (+), (++), and (+++) to indicate the expression levels of SOX9. Negative staining is denoted as (−). Normal tonsil tissue was used as the control. SOX9 highlighted scattered follicular dendritic cells and showed only background staining in the germinal centers. Results of immunoblot (B) and qRT-PCR (C) analysis of endogenous SOX9 protein or SOX9 mRNA levels in DLBCL cell lines. (B-C) Data represent the mean ± standard deviation (SD) from technical triplicates.